1. People's Republic of China Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Yibin Tianyuan Group Co., Ltd.

Yibin Tianyuan Group Co., Ltd.

002386.SZ
Yibin Tianyuan Group Co., Ltd.CN flagShenzhen Stock Exchange
6.16
CNY
+0.11
- -
8.02BMarket Cap
Yibin Tianyuan Group Co., Ltd.
002386.SZ
(Shenzhen Stock Exchange)

Recent

price

6.16

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
6.09
6
6.87
10.48
14.72
12.28
14.32
17.5
19.44
22.77
21.32
18.54
20.04
14.94
10.27
8.68
6.91
Revenue per Share
0.14
0.02
0.08
0.06
0.1
0.02
0.06
0.12
0.17
0.08
0.11
0.63
0.54
0.03
-0.35
0.07
0.11
Basic EPS, GAAP
-1.01
-1.29
0.07
-0.1
-0.57
-0.05
0.2
-0.28
-0.14
0.24
0.48
0.8
0.66
-1.14
-0.79
-0.99
-0.47
Free Cash Flow per Basic Share
0.31
0.35
0.49
0.5
0.64
0.55
0.41
0.43
0.42
0.31
0.28
0.23
0.39
0.2
0.24
0.15
0.11
Dividend per Share
2.04
1.73
1.96
1.92
2.73
2.19
2.24
2.32
2.45
2.25
2.32
2.95
3.51
3.08
2.46
2.51
2.57
Book Value per Share
4.43
3.66
4.19
4.06
5.88
4.2
4.19
4.07
4.67
4.45
4.62
5.2
5.56
6.15
5.38
5.38
5.15
Tangible Book Value per Share
814
943
849
873
624
872
873
873
932
1,015
1,015
1,015
1,015
1,230
1,302
1,302
1,302
Basic Weighted Avg Shares
4,958
5,655
5,828
9,152
9,184
10,704
12,502
15,286
18,123
23,103
21,646
18,825
20,339
18,367
13,367
11,299
8,992
Sales/Revenue/Turnover
4.24
3.99
1.71
2.78
-0.38
0.23
2.35
2.5
3.2
1.87
2.3
5.84
4.12
0.01
-2.03
2.39
3.54
Operating Margin (%)
348
469
449
499
500
509
486
513
550
573
512
434
487
480
511
555
- -
Depreciation Expense
112
21
65
56
61
16
55
103
155
79
116
645
551
40
-460
88
138
Net Income, GAAP
14.58
52.58
39.12
43.11
72.64
115.9
73.49
54.86
19.79
73.96
45.9
14.81
20.59
42.76
- -
74.44
45.32
Effective Tax Rate (%)
2.26
0.37
1.12
0.62
0.66
0.15
0.44
0.67
0.86
0.34
0.54
3.42
2.71
0.22
-3.44
0.78
1.53
Profit Margin (%)
-813
-2,296
-2,649
-3,942
-3,868
-3,122
-2,983
-3,179
-2,462
-3,484
-2,745
-2,291
-2,058
-617
-2,382
-2,623
-2,089
Working Capital
1,616
1,623
2,125
1,289
896
1,672
971
233
706
394
919
1,037
1,900
3,340
3,091
3,218
3,696
LT Debt
4,415
4,230
4,359
4,367
4,382
4,370
4,401
4,324
5,121
5,070
5,249
5,856
6,255
8,190
7,626
7,659
7,735
Total Equity
2.5
1.16
0.59
1.34
-0.09
-0.04
0.7
1.66
4.39
1
2.3
7.61
5.44
0.01
- -
0.45
1.09
Return on Invested Capital (%)
3.74
1.69
2.83
2.09
1.59
0.1
1.52
3.28
5.41
2.34
2.84
8.73
7.89
1.64
- -
1.77
2.37
Return on Capital (%)
7.3
1.26
3.96
3.38
3.58
0.91
2.86
5.15
7.19
3.45
5
24.07
16.77
1.09
-13.15
2.71
4.21
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
4,538
4,611
LT Borrowings
- -
3,218
3,696
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
1,302
1,302
Market Capitalization
6,847
7,095
7,787

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
6,023
7,636
Cash, Cash Equivalents & STI
- -
2,501
2,539
Accounts Receivable, Net
- -
1,057
2,165
Inventories
- -
1,419
1,652
Total Current Liabilities
- -
8,645
9,725
Payables & Accruals
- -
- -
- -
ST Debt
- -
4,538
4,611
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.28%
8.57%
0.44%
Free Cash Flow
-122.16%
-52.94%
24.49%
Net Income, GAAP
-64.79%
-204.03%
-119.1%
Sales/Revenue/Turnover
2.14%
-11.47%
-15.47%
Total Cash Common Dividend
-3.89%
1.54%
-36.56%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,008
3,592
3,375
3,392
13,367
2025
3,141
2,528
- -
2,809
11,299
2026
3,655
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.35
2025
0.01
- -
- -
- -
0.07
2026
0.06
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.24
2025
0.04
- -
- -
- -
0.15
2026
0.03
- -
- -
- -
- -
Similar Companies
IKONICS Corporation (IKNX)
AECI Ltd (AECLY)
Vikas Lifecare Limited (VIKASLIFE.NS)
Carbios SAS (ALCRB.PA)
International CSRC Investment Holdings Co., Ltd. (2104.TW)
Yung Chi Paint & Varnish Mfg.Co.,Ltd (1726.TW)
Business
Yibin Tianyuan Group Co., Ltd. (002386.SZ) operates as a diversified conglomerate primarily engaged in the production and sale of pharmaceuticals, fuses, and copper-based products in China. The company manufactures and distributes a range of core products and services, including fuse products such as low-voltage fuses, high-voltage fuses, and photovoltaic fuses under the Tianyuan brand; pharmaceutical preparations encompassing tablets, capsules, granules, and raw materials like anti-cold medicines and gastrointestinal drugs; and copper processing items such as copper foil, copper strips, and copper wires for applications in electronics and power sectors. It also provides related services in research and development, quality control, and customized manufacturing solutions for industrial clients. Headquartered in Yibin, Sichuan Province, China, the company was founded in 1999 and maintains operations primarily within the domestic Chinese market, with production facilities concentrated in the southwestern region. Yibin Tianyuan Group serves key customer segments including pharmaceutical distributors, electrical equipment manufacturers, renewable energy firms, and electronics producers, operating across the healthcare, electrical components, and new energy materials industries. In recent developments, the company expanded its fuse production capacity through strategic investments in 2024, enhancing output for high-demand photovoltaic and automotive applications amid China's push for renewable energy infrastructure. It formed partnerships with major solar panel producers to supply specialized fuses, bolstering its position in the new energy sector. Additionally, Yibin Tianyuan Group launched new pharmaceutical formulations targeting respiratory and digestive health in late 2024, alongside facility upgrades to meet stringent regulatory standards.